SEB Asset Management AB »

Edgewise Therapeutics shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.5M 207k 31.50

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Paradigm Biocapital Advisors
Baker Bros. Advisors
BlackRock
Henderson Group
Novo A/S
Vanguard Group
Siren
Perceptive Advisors
Driehaus Capital Management
Vanguard Capital Management
Cormorant Asset Management
Braidwell
Morgan Stanley

View all funds holding Edgewise Therapeutics